Literature DB >> 6702894

Osteogenesis imperfecta type II delineation of the phenotype with reference to genetic heterogeneity.

D O Sillence, K K Barlow, A P Garber, J G Hall, D L Rimoin.   

Abstract

A group of fetuses with a perinatally lethal variety of osteogenesis imperfecta (O.I. type II) is characterized by short limbs, and clinical and roentgenological evidence of severe osseous fragility and defective ossification. Forty-eight cases were reviewed and can be subdivided into 3 groups on the basis of small but probably significant differences in clinical and radiographic findings. Group A (38 cases): short, broad, "crumpled" long bones, angulation of tibiae and continuously beaded ribs. Group B (6 cases): short, broad, crumpled femora, angulation of tibiae but normal ribs or ribs with incomplete beading. Group C (4 cases): long, thin, inadequately modelled, rectangular long bones with multiple fractures and thin beaded ribs. Consistency of findings within sibships suggests the groups reflect genetic heterogeneity. An increased frequency of parental consanguinity, sib occurrence with normal parents, and normal mean paternal age at birth, suggest that most cases of O.I. type II represent autosomal recessive traits. Some previously reported cases and the biochemical findings in one case suggest still further genetic heterogeneity.

Entities:  

Mesh:

Year:  1984        PMID: 6702894     DOI: 10.1002/ajmg.1320170204

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  39 in total

1.  The clinical features of osteogenesis imperfecta resulting from a non-functional carboxy terminal pro alpha 1(I) propeptide of type I procollagen and a severe deficiency of normal type I collagen in tissues.

Authors:  W G Cole; P E Campbell; J G Rogers; J F Bateman
Journal:  J Med Genet       Date:  1990-09       Impact factor: 6.318

2.  A case of fetal osteogenesis imperfecta type 2A: longitudinal observation of natural course in utero and pitfalls for prenatal ultrasound diagnosis.

Authors:  Ibuki Kimura; Ryota Araki; Toshiyuki Yoshizato; Shingo Miyamoto
Journal:  J Med Ultrason (2001)       Date:  2015-06-24       Impact factor: 1.314

3.  Perinatal lethal osteogenesis imperfecta (OI type II): a biochemically heterogeneous disorder usually due to new mutations in the genes for type I collagen.

Authors:  P H Byers; P Tsipouras; J F Bonadio; B J Starman; R C Schwartz
Journal:  Am J Hum Genet       Date:  1988-02       Impact factor: 11.025

4.  Lethal osteogenesis imperfecta resulting from a single nucleotide change in one human pro alpha 1(I) collagen allele.

Authors:  D H Cohn; P H Byers; B Steinmann; R E Gelinas
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

5.  Mineralized tissue protein profiles in the Australian form of bovine osteogenesis imperfecta.

Authors:  L W Fisher; L J Denholm; K M Conn; J D Termine
Journal:  Calcif Tissue Int       Date:  1986-01       Impact factor: 4.333

6.  The clinical features of three babies with osteogenesis imperfecta resulting from the substitution of glycine by arginine in the pro alpha 1(I) chain of type I procollagen.

Authors:  W G Cole; C W Chow; J G Rogers; J F Bateman
Journal:  J Med Genet       Date:  1990-04       Impact factor: 6.318

Review 7.  Prenatal diagnosis and prevention of inherited abnormalities of collagen.

Authors:  F M Pope; S C Daw; P Narcisi; A R Richards; A C Nicholls
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

8.  Osteogenesis imperfecta type IIA: evidence for dominant inheritance.

Authors:  I D Young; E M Thompson; C M Hall; M E Pembrey
Journal:  J Med Genet       Date:  1987-07       Impact factor: 6.318

9.  Recurrence risks and prognosis in severe sporadic osteogenesis imperfecta.

Authors:  E M Thompson; I D Young; C M Hall; M E Pembrey
Journal:  J Med Genet       Date:  1987-07       Impact factor: 6.318

10.  Fetal musculoskeletal malformations with a poor outcome: ultrasonographic, pathologic, and radiographic findings.

Authors:  Soo Hyun Lee; Jeong Yeon Cho; Mi Jin Song; Jee Yeon Min; Byoung Hee Han; Young Ho Lee; Byung Jae Cho; Seung Hyup Kim
Journal:  Korean J Radiol       Date:  2002 Apr-Jun       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.